Table 3.
Clinical information, pathologic diagnosis, BRAF and KRAS testing results
Case # | AGE | Gender | Histology Type | Site | Grade | Stage | BRAF | KRAS | CIMP | MSI-PCR |
Pre-existing |
---|---|---|---|---|---|---|---|---|---|---|---|
Adenoma | |||||||||||
BRAF-1 |
60 |
Male |
AC |
Caecum |
2 |
I |
V601E |
Codon 13 |
Low CIMP |
MSI-L |
Tubular adenoma |
BRAF-2 |
47 |
Male |
AC |
Ascending colon |
2 |
I |
V600E |
Codon 13 |
NA |
MSI-S |
Hyperplastic polyp |
SERRATED ADENOMA | |||||||||||
BRAF-3 |
71 |
Female |
AC |
Rt colon |
1 |
III |
V600E |
WT |
NA |
MSI-H |
Unremarkablemucosa |
BRAF-4 |
57 |
Female |
AC |
Rt colon |
3 |
IV |
V600E |
WT |
Low CIMP |
MSI-S |
Unremarkablemucosa |
BRAF-5 |
67 |
Male |
AC |
Recto sigmoid |
2 |
II |
V600E |
WT |
Low CIMP |
MSI-S |
Unremarkablemucosa |
BRAF-6 |
74 |
Female |
AC |
Rt colon |
3 |
II |
V600E |
WT |
Low CIMP |
MSI-H |
Unremarkablemucosa |
BRAF-7 |
66 |
Male |
AC |
Ascending colon |
2 |
III |
V594G |
WT |
Low CIMP |
MSI-L |
Adenoma |
BRAF-8 |
68 |
Male |
AC |
Rt colon |
2 |
IV |
V600E |
WT |
Low CIMP |
MSI-S |
Unremarkablemucosa. |
BRAF-9 |
61 |
Female |
AC |
Rt colon |
1 |
I |
V600E |
WT |
High CIMP |
MSI-H |
Small hyperplasticpolyps |
BRAF-10 |
46 |
Male |
AC |
Sigmoid |
2 |
I |
V600E |
WT |
NA |
MSI-L |
Hyperplastic polyp |
BRAF-11 |
34 |
Male |
AC |
Recto sigmoid |
2 |
III |
V600E |
WT |
Low CIMP |
MSI-S |
Unremarkablemucosa |
BRAF-12 |
71 |
Male |
AC |
Sigmoid |
2 |
III |
V600E |
WT |
NA |
MSI-S |
Hyperplastic polyp |
BRAF-13 |
59 |
Male |
AC |
Rectal |
2 |
III |
V600E |
WT |
High CIMP |
MSI-S |
Tubular adenoma |
BRAF-14 |
66 |
Female |
AC |
Rt colon |
2 |
II |
V600E |
WT |
NA |
MSI-H |
Unremarkable mucosa |
BRAF-15 |
66 |
Male |
AC |
Sigmoid colon |
2 |
II |
V600E |
WT |
Low CIMP |
MSI-S |
No colonic mucosa seen |
BRAF-16 |
73 |
Female |
AC |
Rt colon |
3 |
II |
V600E |
WT |
High CIMP |
MSI-H |
Unremarkable mucosa |
BRAF-17 |
72 |
Male |
AC |
Rt colon |
2 |
II |
V600E |
WT |
High CIMP |
MSI-H |
Unremarkable mucosa |
BRAF-18 |
74 |
Female |
AC |
Sigmoid colon |
2 |
II |
V600E |
WT |
NA |
MSI-L |
Unremarkable mucosa |
BRAF-19 | 55 | Female | MC | Recto sigmoid | 2 | III | V600E | WT | NA | MSI-L | Unremarkable mucosa |